Syndromic congenital myelofibrosis associated with a loss-of-function variant in RBSN
- 9 August 2018
- journal article
- letter
- Published by American Society of Hematology in Blood
- Vol. 132 (6) , 658-662
Abstract
Publisher9s Note: There is a Blood Commentary on this article in this issue.Keywords
This publication has 10 references indexed in Scilit:
- A novel homozygous VPS45 p.P468L mutation leading to severe congenital neutropenia with myelofibrosisPediatric Blood & Cancer, 2017
- Severe congenital neutropenia with neurological impairment due to a homozygous VPS45 p.E238K mutation: A case report suggesting a genotype–phenotype correlationAmerican Journal of Medical Genetics Part A, 2015
- Single point mutation in Rabenosyn-5 in a female with intractable seizures and evidence of defective endocytotic traffickingOrphanet Journal of Rare Diseases, 2014
- A Congenital Neutrophil Defect Syndrome Associated with Mutations inVPS45New England Journal of Medicine, 2013
- The Thr224Asn mutation in the VPS45 gene is associated with the congenital neutropenia and primary myelofibrosis of infancyBlood, 2013
- Rabenosyn-5 defines the fate of the transferrin receptor following clathrin-mediated endocytosisProceedings of the National Academy of Sciences, 2012
- The endocytic pathway acts downstream of Oskar inDrosophilagerm plasm assemblyDevelopment, 2008
- Role of Endocytosis in Cellular Uptake of Sex SteroidsCell, 2005
- Rabenosyn-5 and EHD1 Interact and Sequentially Regulate Protein Recycling to the Plasma MembraneMolecular Biology of the Cell, 2004
- Rabenosyn-5, a Novel Rab5 Effector, Is Complexed with Hvps45 and Recruited to Endosomes through a Fyve Finger DomainJournal of Cell Biology, 2000